Physiologically‐based pharmacokinetic model predictions of inter‐ethnic differences in imatinib pharmacokinetics and dosing regimens-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Physiologically‐based pharmacokinetic model predictions of inter‐ethnic differences in imatinib pharmacokinetics and dosing regimens

Published:2021-10-15 Issue: Volume: Page:
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Adiwidjaja Jeffry¹²^ORCID,Gross Annette S.³^ORCID,Boddy Alan V.⁴^ORCID,McLachlan Andrew J.¹^ORCID

Affiliation:

1. Sydney Pharmacy School, Faculty of Medicine and Health The University of Sydney Sydney NSW Australia

2. Faculty of Pharmacy Gadjah Mada University Yogyakarta Special Region of Yogyakarta Indonesia

3. Clinical Pharmacology Modelling & Simulation, GlaxoSmithKline R&D Sydney NSW Australia

4. UniSA Cancer Research Institute and UniSA Clinical & Health Sciences University of South Australia Adelaide SA Australia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15084

Reference107 articles.

1. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

2. Imatinib Pharmacokinetics in a Large Observational Cohort of Gastrointestinal Stromal Tumour Patients

3. Systematic Review of Population Pharmacokinetic Analyses of Imatinib and Relationships With Treatment Outcomes

4. Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib

5. METABOLISM AND DISPOSITION OF IMATINIB MESYLATE IN HEALTHY VOLUNTEERS

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically based pharmacokinetic modeling of imatinib and N‐desmethyl imatinib for drug–drug interaction predictions;CPT: Pharmacometrics & Systems Pharmacology;2024-03-14

2. Ultrasensitive detection of imatinib in human serum using a gold-based paper sensor;Journal of Chromatography B;2024-02

3. Kinase Inhibitors FDA Approved 2018–2023: Drug Targets, Metabolic Pathways, and Drug-Induced Toxicities;Drug Metabolism and Disposition;2024-01-29

4. Pharmacokinetics of Imatinib Mesylate and Development of Limited Sampling Strategies for Estimating the Area under the Concentration–Time Curve of Imatinib Mesylate in Palestinian Patients with Chronic Myeloid Leukemia;European Journal of Drug Metabolism and Pharmacokinetics;2023-11-25

5. Prediction of trough concentration and ALK occupancy in plasma and cerebrospinal fluid using physiologically based pharmacokinetic modeling of crizotinib, alectinib, and lorlatinib;Frontiers in Pharmacology;2023-11-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3